,2 In recent clinical practice guidelines, SGLT2i have been recommended for adults with CKD with an estimated glomerular filtration rate (eGFR) of 20 to less than 45 mL/min/1.73 m2, or with an eGFR of 45–90 mL/min/1.73 m2 with either type 2 diabetes or urine albumin-to-creatinine ratio (uACR) ≥ 200 mg/g.3, 4, 5 CKD is one of the leading causes of morbidity and mortality globally with substantial economic burden,6 which is especially pronounced in low- and middle-income countries where access to kidney dialysis or transplantation may be very limited.7 Here, ALB is linked to chronic kidney disease.